Translating science into innovative diagnostic solutions

Developing solutions for important global health issues

Quadrant Biosciences works with top academic institutions, medical researchers and engineers to translate breakthrough findings into thoughtfully developed and scientifically sound assessment applications.

Our evolutionary advancements in brain health assessment, autism and Parkinson’s detection, will have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions going forward. Supported through private and state funding, one of these key technologies, ClearEdge, is currently available in the market and the others are slated for a 2018 release.

Quadrant Biosciences in the News!

How a Hockey Scare Led Banking Vet to Issue First Digital Shares

Read the article on Bloomberg

HOF Players Foundation and Quadrant Biosciences Partner to Address Former Football Players’ Health Concerns

New brain health assessment toolkit to track players’ brain health over time

Read the Press Release

Understanding microRNA: These tiny keys could unlock a treasure trove of medical knowledge

Dr. Frank Middleton is featured in the most recent Upstate Medical University Health magazine!

Read the article in Upstate Health here

Groundbreaking Epigenetic Research Receives Widespread Media Attention

We are very excited about the recent national and international media coverage of Dr. Steven Hicks’ research at Penn State regarding epigenetic saliva biomarkers for concussion. This groundbreaking work, which Quadrant Biosciences is privileged to support, was recently published in the esteemed journal JAMA Pediatrics. Below is a tv news story out of Pennsylvania, a story on CNN, and a great interview with Dr. Hicks on New Zealand radio.

Quadrant Biosciences is pleased to have been selected as a StartupNY company.

Our Research Partners